Sarah Nagle

Sarah Nagle

Oregon Health & Science University - Portland / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 892009
person_outline Sarah Nagle's MOST POPULAR ARTICLES
1-) Cilta-cel or standard care in lenalidomide-refractory multiple myeloma New England Journal of Medicine 389 (4), 335-347, 2023
2-) Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 JAMA oncology 7 (8), 1167-1175, 2021
3-) Outcomes of patients with relapsed/refractory diffuse large B‐cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era American journal of hematology 88 (10), 890-894, 2013
4-) A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset The Journal of rheumatology 39 (6), 1241-1247, 2012
5-) A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onsetFA Mendoza, SJ Nagle, JB Lee, SA JimenezThe Journal of rheumatology 39 (6), 1241-1247, 20121232012